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Abstract The N-terminal region of the K integrin subunits is
predicted to fold into a L-propeller domain. Using K562 K4
transfectants we show that mutations at K4 subunit residues
Gly130 and Gly190 affect the conformation of this domain
causing a reduction in the recognition of K4 by anti-K4 antibodies
which map to the L-propeller. The improper K4 conformation
also led to an altered association with the L1 subunit, and to a
lack of K4L1 adhesion to VCAM-1 and CS-1/fibronectin, as well
as an abolishment of anti-K4- and anti-L1-dependent homotypic
aggregation. The total conservation of Gly130 and Gly190 among
integrin K subunits suggests their importance in the correct
folding of their respective L-propeller domains, and thus, in the
adhesive activity of the integrins.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
VLA-4 (K4L1) is a member of the L1 subfamily of the in-
tegrins, which mediates cell adhesion to the connecting seg-
ment-I (CS-1) region of ¢bronectin, and to vascular cell ad-
hesion molecule-1 (VCAM-1) [1^5]. VLA-4, as well as other
L1 integrins, can exist in di¡erent states of activation [6], and
their activity can be rapidly modulated by various stimuli,
including divalent cations and certain anti-integrin L1 subunit
monoclonal antibodies (mAb) [6^8]. Interaction with other
sequences on ¢bronectin [9^11], as well as with thrombospon-
din [12], requires VLA-4 to be activated. VLA-4 also interacts
with the bacterial coat protein invasin in an activation-inde-
pendent manner [13].
VLA-4 is involved in leukocyte recruitment to sites of in-
£ammation, and it has been implicated in several in£amma-
tory pathologies [14,15]. In addition, VLA-4 participates in
the adhesion of hematopoietic progenitors to bone marrow
stroma [16,17], and it is required for normal development of
both T and B cells in the bone marrow [18].
A characteristic feature of integrin K subunit N-terminal
domains is the presence of seven homologous repeats of ap-
proximately 60 amino acids each [19], which have been pro-
posed to fold into a L-propeller domain, based on the pres-
ence of potential secondary structures of integrin K subunits
similar to the secondary structures found in several proteins
with L-propeller domains [20]. According to this model, the
upper surface of the L-propeller contains the K subunit ligand-
binding sites. Di¡erent epitopes involved in VLA-4-mediated
cell adhesion are predicted to be present on this upper surface
of the K4 L-propeller. The epitope B includes the main inter-
action sites with CS-1-containing ¢bronectin (FN) fragments
and with VCAM-1, and it has been subdivided into epitopes
B1 and B2, since some of the antibodies which blocked these
interactions also triggered homotypic cell aggregation [21].
Using K4 murine/human chimeric constructs expressed in
mammalian cells, it has been shown that epitopes B1 and
B2 map to K4 residues 100^268 [22,23]. We recently reported
that K4 amino acids 151^155 are important for the structure
of the epitope B2 and that mutations at K4 Gln152 substan-
tially impaired transfectant adhesion to a CS-1-containing
fragment of ¢bronectin [24]. The K4 epitope A maps to the
most K4 N-terminal 100 amino acids, is partially involved in
cell adhesion to CS-1/FN but not to VCAM-1, and mAb
against this epitope are also able to induce homotypic aggre-
gation [21^23]. We previously showed that K4 residues
Arg89Asp90 form part of the epitope A, and are implicated
in the modulation of VLA-4 adhesion to CS-1/FN [25].
The folding of the di¡erent functional epitopes in the L-
propeller domain is therefore essential for the correct activity
of VLA-4. The implication of small regions or individual res-
idues in the folding of this domain remains to be solved. In
the present study we have investigated the participation of
two glycine residues located on the epitope B of K4 which
are totally conserved among K subunits, in the folding of
the K4 L-propeller domain and in the function of VLA-4.
2. Materials and methods
2.1. Cells, VLA-4 ligand proteins and antibodies
The human cell line K562 was cultured in PRMI 1640 medium
supplemented with 10% fetal calf serum and antibiotics (complete
medium). K562 K4 transfectants were maintained in the same medium
containing 1 mg/ml of G418 (Calbiochem). The recombinant FN-H89
fragment of ¢bronectin which contains the CS-1 site, and recombinant
soluble VCAM-1 (sVCAM-1) consisting of domains 1 to 4 were gen-
erated as previously described [24]. Monoclonal antibodies used in
this study included P3X63 [26], TP1/36 (anti-CD43) [27], TS2/16
and Lia 1/2.1 (anti-VLA-L1 subunit) [28,29], SAM-1 (anti-K5) [30],
and the following anti-K4: HP1/7, HP1/2, HP2/1, HP2/4 [31], and
B-5G10 [32].
2.2. Site-directed mutagenesis and transfections
The K4 cDNA in Bluescript [19] was subjected to site-directed mu-
tagenesis using the Bio-Rad Muta-Gene kit, as recommended. Oligo-
nucleotides representing K4 bp 513^544 (for G130R) and 692^721 (for
G190S) were used as primers containing selected mismatches. Trans-
fectants expressing mutations at K4 Asn123Glu124 have been described
[24]. Base substitutions at sites of mutations raised new endonuclease
restriction sites, which facilitated the identi¢cation of the mutations
introduced, that were later con¢rmed by DNA sequencing using a
Perkin-Elmer automatic DNA sequencer (Model ABI Prism). Mu-
tated K4 inserts were excised and ligated into the pFNeo expression
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vector [33,34] in SalI-XbaI sites. For transfection, 25 Wg of pFNeo
vector containing mutant K4 was electroporated into 107 K562 cells,
and after 48 h, 1 mg/ml of G418 was added to the media. G418-
resistant cells were analyzed by £ow cytometry using a Coulter Epics
XL, and enriched for VLA-4-positive cells by immunomagnetic bead
selection (Dynal Co. Norway), using the anti-K4 mAb B-5G10.
2.3. Cell labeling and immunoprecipitation
Transfectants were surface-labeled with Na[125I] (Amersham Cor-
poration, UK) using lactoperoxidase, and solubilized with 0.5% NP-
40 as previously reported [34]. For immunoprecipitation, the super-
natants were precleared with Protein A-Sepharose beads, followed by
incubation at 4‡C with antibodies. The immunocomplexes were har-
vested by incubation with Protein A-Sepharose beads, boiled and
analyzed by SDS-PAGE using 7% polyacrylamide gels and non-re-
ducing conditions.
2.4. Cell adhesion and aggregation assays
For cell adhesion, K4 transfectants or K562 cells were labeled in
complete medium with the £uorescent dye BCECF-AM (Molecular
Probes, the Netherlands), and then added in RPMI medium contain-
ing 0.4% BSA to 96-well dishes (Costar) (6U104 cells/well) coated
with FN-H89 or sVCAM-1 (100 Wl/well). After incubation for 20
min at 37‡C, unbound cells were removed by three washes with
RPMI medium, and adhered cells quanti¢ed using a £uorescence an-
alyzer (CytoFluor 2300, Millipore Co.). Homotypic cell aggregation
assays were performed essentially as described [35], and the degree of
cell aggregation was measured at 3, 7 and 20 h in a semiquantitative
manner as reported [36].
3. Results
Within the N-terminal 200 amino acids of the L-propeller
K4 integrin subunit domain, two glycine residues at positions
130 and 190 are completely conserved among integrin K sub-
units (Fig. 1A) and are found at structurally equivalent sites
in this domain, the loops connecting strands 2 and 3 of the
W2 and W3 sheets, respectively [20]. According to the Pepti-
destructure program, the Gly130 is contained in a random coil
sequence, while the Gly190 forms part of a predicted L-turn, as
previously reported [37]. To investigate the importance of K4
Gly130 and Gly190 on the structure and function of VLA-4, we
mutagenized both residues and the mutated full length K4
cDNAs in the expression vector pFNeo were transfected
into VLA-4-negative K562 cells. The resulting geneticin-resist-
ant transfectants were designated as indicated in Fig. 1B. We
also used throughout the work the NE(123^124)HA transfec-
tants which express K4 mutated at Asn123Glu124, that have
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Fig. 1. Sequence alignments and mutagenesis of the integrin K4 sub-
unit. A: Alignments of a segment at the N-terminal end of the K4
subunit which includes the residues Gly130 and Gly190, and the cor-
responding on K5, KIIb and KM subunits. Glycines in bold are lo-
cated at structurally equivalent loop positions in the L-propeller do-
main. B: Schematic diagram of the N-terminal end of K4 and site-
directed mutagenesis of the K4 cDNA. Shown are the single and
double mutations introduced on selected K4 residues and the desig-
nation of the K4 mutant transfectants. C denotes the cysteine resi-
dues.
Fig. 2. Flow cytometry analysis of K562 K4 transfectants. 4M7
(wild-type K4 transfectants) and the mutant G130R and G190S
were incubated at 4‡C for 40 min with saturating concentrations of
di¡erent anti-K4, anti-L1 or control mAb. After washing, cells were
incubated at 4‡C for 30 min with FITC-conjugated secondary anti-
body (Dako, Denmark), and ¢nally analyzed using a Coulter Epics
XL £ow cytometer.
Fig. 3. Cell surface labeling of K4 transfectants. 4M7, G190S and
G130R were surface iodinated, solubilized and immunoprecipitated
with anti-K4 B-5G10 or HP2/1, anti-L1 TS2/16 or with control P3
mAb. Immunoprecipitates were analyzed by electrophoresis using
7% polyacrylamide gels, and bands detected by autoradiography. In-
dicated are the migrations of K5, K4=80, K4=70 and L1 subunits.
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previously been characterized [24]. Analysis of G130R and
G190S transfectants by £ow cytometry showed a very similar
pattern of K4 reactivity with anti-K4 mAb which binds to
di¡erent regions on the K4 molecule [21^23]. Epitopes A
and B2 on K4 were clearly unreactive towards anti-K4 HP1/
7 and HP2/4 mAb, respectively, while some reactivity was
observed with the epitope B1 HP1/2 mAb (Fig. 2). The epit-
ope C B-5G10 mAb reacted to a higher degree with K4 mu-
tated at Gly130 than with K4 mutated at Gly190. In contrast,
K4 on 4M7 wild-type transfectants (Fig. 2 and [25]), as well as
on NE(123^124)HA transfectant mutants (not shown, [24]),
reacted comparably with all anti-K4 mAb.
The K4 subunit on the 4M7 cells showed a typical pattern
of cleaved K4=80 and K4=70 proteolytic fragments expression
[34], which were associated on the cell surface with the L1
subunit (Fig. 3, lanes b, e, f) as detected in cell surface iodi-
nation followed by immunoprecipitation using anti-K4 epitope
C B-5G10 or epitope B1 HP2/1, or anti-L1 TS2/16 mAb. The
80 kDa and 70 kDa K4 fragments from G130R and G190S
transfectants were detected in immunoprecipitates using B-
5G10 but not HP2/1 mAb (Fig. 3, lanes g, h, i, j). In the
same cells, the endogenous L1 subunit immunoprecipitated
by TS2/16 migrated in SDS-PAGE identically to L1 from
4M7 transfectants, and the same antibody co-immunoprecipi-
tated the K5, but not the K4 subunit in G130R and G190S
cells (Fig. 3, lanes c, d). Likewise, the B-5G10 mAb failed to
co-immunoprecipitate the endogenous L1 subunit in G130R
and G190S cells (Fig. 3, lanes g, i), although we detected two
iodinated polypeptides speci¢cally co-immunoprecipitated by
this antibody, showing an electrophoretic mobility close to
endogenous L1, which were absent in the TS2/16 immunopre-
cipitates. Experiments of immunoprecipitation with B-5G10
of lysates from these cells, followed by Western blot using
the TS2/16 anti-L1 mAb, did not reveal any associated L1
subunit (not shown), suggesting that K4L1 association is prob-
ably very weak and it might be lost during cell lysis/immuno-
precipitation.
The adhesion of G130R to sVCAM-1 and to FN-H89, a
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Fig. 4. Adhesion of K4 transfectants to FN-H89 and sVCAM-1. Cells were labeled with BCECF-AM and added to 96-well microtiter plates
coated with increasing concentrations of FN-H89 or sVCAM-1. After 20 min incubation at 37‡C, plates were washed and adhesion was quanti-
¢ed using a £uorescence analyzer. Each panel shows a representative result from at least four experiments and each point is the mean of tripli-
cate determinations, with a standard deviation of 6 10%. K562 cells showed no adhesion at any concentration of FN-H89 or sVCAM-1 tested
(not shown).
Table 1
Homotypic aggregation of wild-type and mutant K4 transfectants induced by anti-K4 mAb which recognize di¡erent epitopes on the K4 subunit
CD43 L1 K4
Cells P3 TP1/36 Lia1/2 HP1/7 HP2/1 HP2/4 B-5G10
K562 0 5 0 0 0 0 0
4M7 0 5 5 4 2 4 0
NE(123^124)HA 0 5 5 4 2 4 0
G130R 0 5 1 0 0 0 0
G190S 0 5 1 0 0 0 0
K562 or transfectant K562 cells were incubated for 3 h with anti-L1 or with anti-K4 epitope A (HP1/7, B1 (HP2/1), B2 (HP2/4), or C (B-5G10). Cell
aggregation was scored visually: 0, no aggregation; 1, 6 10% of cells aggregating; 2, 10^50% of cells aggregating; 3, 50^80% of cells aggregating;
4, s 80% of cells in small aggregates; 5, s 90% of cells in large and compact aggregates. No aggregation and nearly 100% aggregation were
determined with the controls P3X63 and TP1/36 mAb, respectively.
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¢bronectin fragment which contains the CS-1 region, was dra-
matically impaired, whereas G190S cells showed a minimal
adhesion to high sVCAM-1 concentrations, but not to FN-
H89 (Fig. 4). In contrast, NE(123^124)HA and 4M7 trans-
fectants adhered e⁄ciently to increasing concentration of the
ligands. The adhesion of G130R and G190S could not be
restored by the stimuli TS2/16 or by Mn2 ions, known to
increase the a⁄nity of VLA heterodimers for their ligands,
nor by PMA, an agent that stimulates the clustering of integ-
rins at the cell surface (not shown).
Homotypic aggregation assays showed a total absence of
response to the epitope A HP1/7 and epitope B2 HP2/4
mAb by G130R and G190S cells, while high degree of aggre-
gation was induced by these mAb in 4M7 and NE(123^
124)HA transfectants (Table 1). Interestingly, G130R and
G190S cells even failed to aggregate in response to the anti-
L1 Lia 1/2.1 mAb. As anti-B1 mAb-mediated homotypic ag-
gregation is dependent on the presence of cell surface VLA-4
[38], these data support the hypothesis of an altered K4L1 cell
surface association. All transfectants aggregated equally well
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Fig. 5. Localization of Gly130 and Gly190 on the model for the integrin K4 subunit L-propeller domain (20). A: Top view. B: Side view. Also
indicated are the positions for Gln152Asp153 and Asn123Glu124. The Cys150 is shown to help the identi¢cation of other residues.
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in response to the positive control TP1/36 anti-CD43 mAb
(Table 1).
4. Discussion
In this study we show that mutations at two glycines on the
K4 subunit at positions 130 and 190 a¡ect the conformation
of K4, its association with the L1 subunit, and leads to a lack
of VLA-4-mediated adhesive activity. Both glycines are lo-
cated on structurally equivalent loops on the K4 L-propeller
upper surface (Fig. 5), which has been proposed to contain
key sites for interaction of VLA-4 with its ligands [20]. The
total conservation of these glycines among K integrin subunits
suggests that they might play an important role in the correct
folding of the L-propeller domain and the whole K subunit
molecules. That K4 mutated at glycines 130^190 has an incor-
rect conformation is supported by results showing a marked
decrease in its reactivity with antibodies which recognize
structurally distant regions on the L-propeller domain, such
as K4 epitopes A, B1 and B2. This could be the consequence
of the introduction of the substitutions at Gly130 and Gly190
which might disrupt the structure of the loops connecting
strands 2 and 3 of W2 and W3 sheets, respectively. An addi-
tional mechanism contributing to the lack of recognition of
the L-propeller domain by anti-K4 mAb could involve the
incorrect association of K4 with the L1 subunit, similarly to
what has been observed with anti-KL (CD11a) antibodies
which map to the L-propeller of this K subunit [39].
Transfectant surface iodination and immunoprecipitation
experiments showed that in spite of the fact that the endoge-
nous L1 subunit is expressed on the K562 K4 transfectants in
association with the K5 subunit, no endogenous L1 subunit
was clearly detected in association with mutant K4. We did
observe, however, two iodinated proteins on the cell surface of
the mutant transfectants, speci¢cally co-immunoprecipitated
by anti-K4 mAb. Whether these two proteins correspond to
anomalously processed L1 forms remains to be studied. It is
well accepted that the integrin L subunits are made in excess
over the K subunits, and that non-associated K or L subunits
are not transported to the cell surface, but remain in cytoplas-
mic vesicles before they are degraded [40,41]. The present data
indicate that K4 mutated at Gly130 and Gly190 is expressed on
the surface of the transfectants in an altered conformation,
and suggest that it might be defectively associated with un-
processed L1 forms, this association being very weak and
probably lost during lysis and immunoprecipitation proce-
dures. The addition of Mn2 ions during lysis/immunopreci-
pitation did not in£uence the degree nor the quality of the
recovered L1 subunits (not shown). Functional data support-
ing this hypothesis come from homotypic aggregation results,
which show that not only aggregating anti-K4 mAb failed to
induce response, but even aggregating anti-L1 mAb failed to
do so, indicating that considerable conformational changes
had occurred on the K4L1 heterodimer. In another previous
study it was also noticed a considerable reduction in the L1
subunit co-immunoprecipitated with anti-K4 antibodies from
transfectants expressing K4 mutated at Gly190 [37], which con-
¢rm the present results.
As expected from an altered K4L1 association and incorrect
K4 conformation, transfectants expressing mutations at K4
Gly130 and Gly190 showed a dramatic impairment of VLA-4-
mediated adhesion to VCAM-1 and FN-H89. The adhesion of
G130R and G190S to VLA-4 ligands was not restored by
stimuli which increase the a⁄nity or the avidity of VLA het-
erodimers for their ligands, con¢rming that an important
change in K4L1 conformation had occurred, and that the ad-
hesion impairment was not due to a⁄nity or avidity modu-
lation. These results do not rule out that Gly130 and Gly190
could play some role in VLA-4 adhesion to its ligands. An K4
amino acid which is likely to be essential in the interaction of
VLA-4 with VCAM-1 and CS-1 is Tyr187, which is found on
the top surface of the L-propeller [37,42]. We have also shown
that K4 residues Gln152Asp153, which are located on the upper
surface of the L-propeller (Fig. 5), modulate VLA-4-mediated
adhesion to ¢bronectin [24], probably by in£uencing the struc-
ture of the ligand-binding site, where the Tyr187 is found.
The results from the present studies will contribute to a
better knowledge of the relations between the structure and
the function of the integrins.
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